# Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device

> **NCT04199793** · NA · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Thromboembolism
- Hemolysis
- Stroke

## Interventions

- **DEVICE:** Lavare On
- **DEVICE:** Lavare Off

## Key facts

- **NCT ID:** NCT04199793
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-10
- **Primary completion:** 2021-08-10
- **Final completion:** 2021-08-10
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The device (HeartWare) was recalled and discontinued by the FDA
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04199793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04199793, "Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04199793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
